Add this result to my export selection Revised SPC: Palforzia (peanut protein as defatted powder of Arachis hypogaea L., semen [peanuts]) Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 11 March 2021 This is indicated for the treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy, in conjunction with a peanut-avoidant diet. It may be continued in patients 18 years... Read Summary Type: Guidance (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Duloxetine capsules Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 09 February 2021 SPC updated to include caution in the elderly, risk of serotonin syndrome when using concomitantly with serotonergic agents and details a new potential adverse effect of treatment of postpartum... Read Summary Type: Guidance (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Venlafaxine Tablets Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 09 February 2021 SPC details a new potential adverse effect of treatment of postpartum haemorrhage (frequency unknown). Read Summary Type: Guidance (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Nimenrix (meningococcal groups A, C, W-135 and Y conjugate vaccine) powder and solvent for solution for injection in pre-filled syringe Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 01 March 2021 Lymphadenopathy has been added to SPC as an adverse effect of unknown frequency. Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Klaricid (clarithromycin) preparations Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 02 March 2021 SPC now notes potential interaction with methadone, a CYP3A4 substrate, whose concentration may be elevated, when given concomitantly with clarithromycin. Close monitoring is advised. Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Vermox (mebendazole) tablets Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 02 March 2021 SPC updated to recommend that owing to limited data, treatment should not be given to those <1 year, and that in those aged 1-2 years mebendazole should only be given if the potential benefit... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Testogel (testosterone) gel Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 02 March 2021 SPC updated in line with PRAC recommendation to highlight caution in use in those with risk factors for venous thromboembolism owing to reports of thrombotic events with treatment. Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Somavert (pegvisomant) powder and solvent for solution for injection Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 26 February 2021 SPC advises that since growth hormone-secreting pituitary tumours may sometimes expand, causing serious complications (e.g. visual field defects), it is essential that all patients be carefully... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection Revised SPC: Velcade (bortezomib) 3.5mg powder for solution for injection Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 26 February 2021 SPC notes that Guillain-Barré syndrome and demyelinating polyneuropathy have been added as adverse events (frequency rare). Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)
Add this result to my export selection New product: Angusta (misoprostol) 25 microgram tablets Source: electronic Medicines Compendium - eMC (Remove filter) Published by electronic Medicines compendium, 03 March 2021 Angusta is licensed for induction of labour. The recommended dosing regimen is 25 mcg orally every 2 hours or 50 mcg orally every four hours according to hospital practice, maximum dose 200 mcg over... Read Summary Type: Prescribing and Technical Information (Add filter) Type: Medicines Current Awareness (Remove filter)